Categories: Press-Releases

Dexlevo’s GOURI Symposium and Brand Event at IMCAS 2023


SEOUL, South Korea–()–Dexlevo, a company specializing in aesthetic medical devices, successfully held a symposium dedicated to its exclusive product, ‘GOURI’, at the IMCAS World Congress 2023 in Paris. IMCAS (International Master Course on Aging Science), held from Jan 26th to Jan 28th in Paris, France, is one of the world’s three major aesthetics anti-aging societies.

Over 200 doctors and companies who visited Dexlevo’s booth showed great interest in GOURI – a unique injectable that provides a fundamental solution to anti-aging.

GOURI symposium titled “Universal Anti-Aging Treatment” was conducted by an Australian dermatologist Dr. Paul Han, who apart from giving a lecture also demonstrated a new GOURI treatment protocol which lately has gained increasing popularity among doctors who use GOURI. Dr. Paul commented, “While keeping the results as great as we had with the previous protocol, the new one dramatically improves the patient’s experience and reduces the patient’s fear of treatment due to pain.”

An exclusive Dexlevo’s brand event called Gorgeous GOURI Night was held on the evening of Jan 26th. It was a customized event where GOURI doctors and distributors worldwide could share their experience and knowledge about the product. After the “Gorgeous GOURI Experience” session, where doctors freely presented their cases and treatment experiences, guests got a chance to experience Korean traditional music – gugak

– and clothing – hanbok.

Dexlevo’s representative said, “Through Gorgeous GOURI Night, an exclusive event dedicated solely to GOURI, we aimed to enhance product understanding and promote brand awareness. It was an opportunity for doctors to expand their network” and added, “We plan to keep demonstrating the excellence of GOURI through various marketing activities, such as holding brand events and participating in international anti-aging conferences.”

Dexlevo’s GOURI is the world’s first liquefied polycaprolatone (PCL) collagen stimulator that naturally spreads throughout the face after injection, including the area around the eyes, to induce collagen production.



Source link

The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

Business Wire

Recent Posts

Share repurchase programme

[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…

21 hours ago

Gyroscope Market Size, Share And Growth Analysis For 2024-2033

[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…

21 hours ago

Casting Off the Caste System and its Stigma: Empowering the Forgotten Indigenous People of India with Human Rights

[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…

21 hours ago

Alipay+ Enables Digital Payment of 14 Overseas E-wallets from 9 Countries and Regions in Hong Kong to Support City’s Global Travel Drive

In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…

21 hours ago

Celebrate "Bleach: Brave Souls" Reaching Over 90 Million Downloads Worldwide with "The Future Society Zenith Summons: Cyber" Featuring New Versions of Ulquiorra, Orihime, and Nnoitora

[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…

22 hours ago

TransAlta Declares Dividends

[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…

2 days ago